FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2808565587> ?p ?o ?g. }

• W2808565587 endingPage "540" @default.
• W2808565587 startingPage "530" @default.
• W2808565587 abstract "Objective During the past few years, there has been a surge in the use of catheter-directed thrombolysis (CDT) for acute pulmonary embolism (PE), in the form of either standard CDT or ultrasound-assisted CDT (usCDT). This is a systematic review and meta-analysis of all published series on contemporary CDT for acute PE seeking to determine their clinical efficacy, stratifying by PE severity and CDT modality. Methods A comprehensive MEDLINE and Embase search was performed to identify studies that reported outcomes of CDT for acute PE published from 2009 to July 2017. Outcomes included clinical success (in-hospital survival with stabilization of hemodynamics, without decompensation or any major complication), in-hospital mortality, major bleeding, right ventricular/left ventricular ratio, and Miller score changes after CDT. Meta-analyses assumed random effects. Results Twenty studies with 1168 patients were included in the meta-analysis. Available for subgroup analysis were 210 patients with high-risk PE and 945 patients with intermediate-risk PE; 181 patients received CDT using a standard multiside hole catheter, and 850 received usCDT. The pooled average right ventricular/left ventricular improvement and Miller score drop after CDT were 0.30 (95% confidence interval [CI], 0.22-0.39) and 8.8 (95% CI, 7.1-10.5). For high-risk PE, the pooled estimate for clinical success was 81.3% (95% CI, 72.5%-89.1%), the 30-day mortality estimate was 8.0% (95% CI, 3.2%-14.0%), and major bleeding was 6.7% (95% CI, 1.0%-15.3%). For intermediate-risk PE, the pooled estimate for clinical success was 97.5% (95% CI, 95.3%-99.1%), the 30-day mortality was 0% (95% CI, 0%-0.5%), and major bleeding was 1.4% (95% CI, 0.3%-2.8%). In high-risk PE, clinical success for CDT and usCDT was 70.8% (95% CI, 53.4%-85.8%) and 83.1% (95% CI, 68.5%-94.5%), respectively. In intermediate-risk PE, clinical success for CDT and usCDT was 95.0% (95% CI, 88.5%-99.2%) and 97.5% (95% CI, 95.0%-99.4%), respectively. Conclusions Catheter thrombolysis has high clinical success rates in both high- and intermediate-risk PE, but higher mortality and bleeding rates should be anticipated in high-risk PE. Ultrasound-assisted thrombolysis may be more effective than standard CDT in the higher risk population." @default.
• W2808565587 created "2018-06-21" @default.
• W2808565587 creator A5006752343 @default.
• W2808565587 creator A5021911875 @default.
• W2808565587 creator A5028485276 @default.
• W2808565587 creator A5029665413 @default.
• W2808565587 creator A5047489604 @default.
• W2808565587 creator A5047834812 @default.
• W2808565587 creator A5055061698 @default.
• W2808565587 creator A5072920508 @default.
• W2808565587 date "2018-07-01" @default.
• W2808565587 modified "2023-10-02" @default.
• W2808565587 title "A meta-analysis of outcomes of catheter-directed thrombolysis for high- and intermediate-risk pulmonary embolism" @default.
• W2808565587 cites W1141106418 @default.
• W2808565587 cites W1498315669 @default.
• W2808565587 cites W1565357639 @default.
• W2808565587 cites W1976590154 @default.
• W2808565587 cites W1996653002 @default.
• W2808565587 cites W2002821499 @default.
• W2808565587 cites W2011611174 @default.
• W2808565587 cites W2011772004 @default.
• W2808565587 cites W2036684303 @default.
• W2808565587 cites W2050022728 @default.
• W2808565587 cites W2056009631 @default.
• W2808565587 cites W2083658263 @default.
• W2808565587 cites W2107328434 @default.
• W2808565587 cites W2107941853 @default.
• W2808565587 cites W2124507123 @default.
• W2808565587 cites W2124971489 @default.
• W2808565587 cites W2133170459 @default.
• W2808565587 cites W2134833483 @default.
• W2808565587 cites W2144837642 @default.
• W2808565587 cites W2145404820 @default.
• W2808565587 cites W2146066346 @default.
• W2808565587 cites W2156917466 @default.
• W2808565587 cites W2158250530 @default.
• W2808565587 cites W2159007980 @default.
• W2808565587 cites W2165595497 @default.
• W2808565587 cites W2202038173 @default.
• W2808565587 cites W2225937646 @default.
• W2808565587 cites W2238383377 @default.
• W2808565587 cites W2286884922 @default.
• W2808565587 cites W2289603112 @default.
• W2808565587 cites W2325152935 @default.
• W2808565587 cites W2344523019 @default.
• W2808565587 cites W2411803413 @default.
• W2808565587 cites W2502528065 @default.
• W2808565587 cites W2521009050 @default.
• W2808565587 cites W2521914118 @default.
• W2808565587 cites W2575416656 @default.
• W2808565587 cites W2587599730 @default.
• W2808565587 cites W2599324752 @default.
• W2808565587 cites W2773567595 @default.
• W2808565587 cites W2981438721 @default.
• W2808565587 doi "https://doi.org/10.1016/j.jvsv.2018.03.010" @default.
• W2808565587 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29909859" @default.
• W2808565587 hasPublicationYear "2018" @default.
• W2808565587 type Work @default.
• W2808565587 sameAs 2808565587 @default.
• W2808565587 citedByCount "52" @default.
• W2808565587 countsByYear W28085655872018 @default.
• W2808565587 countsByYear W28085655872019 @default.
• W2808565587 countsByYear W28085655872020 @default.
• W2808565587 countsByYear W28085655872021 @default.
• W2808565587 countsByYear W28085655872022 @default.
• W2808565587 countsByYear W28085655872023 @default.
• W2808565587 crossrefType "journal-article" @default.
• W2808565587 hasAuthorship W2808565587A5006752343 @default.
• W2808565587 hasAuthorship W2808565587A5021911875 @default.
• W2808565587 hasAuthorship W2808565587A5028485276 @default.
• W2808565587 hasAuthorship W2808565587A5029665413 @default.
• W2808565587 hasAuthorship W2808565587A5047489604 @default.
• W2808565587 hasAuthorship W2808565587A5047834812 @default.
• W2808565587 hasAuthorship W2808565587A5055061698 @default.
• W2808565587 hasAuthorship W2808565587A5072920508 @default.
• W2808565587 hasConcept C126322002 @default.
• W2808565587 hasConcept C141071460 @default.
• W2808565587 hasConcept C164705383 @default.
• W2808565587 hasConcept C2776265017 @default.
• W2808565587 hasConcept C2778721985 @default.
• W2808565587 hasConcept C2779581417 @default.
• W2808565587 hasConcept C44249647 @default.
• W2808565587 hasConcept C500558357 @default.
• W2808565587 hasConcept C71924100 @default.
• W2808565587 hasConcept C95190672 @default.
• W2808565587 hasConceptScore W2808565587C126322002 @default.
• W2808565587 hasConceptScore W2808565587C141071460 @default.
• W2808565587 hasConceptScore W2808565587C164705383 @default.
• W2808565587 hasConceptScore W2808565587C2776265017 @default.
• W2808565587 hasConceptScore W2808565587C2778721985 @default.
• W2808565587 hasConceptScore W2808565587C2779581417 @default.
• W2808565587 hasConceptScore W2808565587C44249647 @default.
• W2808565587 hasConceptScore W2808565587C500558357 @default.
• W2808565587 hasConceptScore W2808565587C71924100 @default.
• W2808565587 hasConceptScore W2808565587C95190672 @default.
• W2808565587 hasIssue "4" @default.
• W2808565587 hasLocation W28085655871 @default.
• W2808565587 hasLocation W28085655872 @default.

• next